<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01474811</url>
  </required_header>
  <id_info>
    <org_study_id>11-1991</org_study_id>
    <nct_id>NCT01474811</nct_id>
  </id_info>
  <brief_title>HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network</brief_title>
  <official_title>HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients
      undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic
      and community practices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HCV-TARGET is a longitudinal, observational study that will create a carefully maintained
      research registry of HCV patients treated with antiviral therapies designed to rapidly inform
      strategies for better management of populations underrepresented in clinical trials, identify
      and remediate educational gaps relative to treatment guidelines and adverse event management
      in order to optimize rates of sustained virological response (SVR), and serve as the core
      resource for important collaborative translational studies utilizing biospecimens and
      clinical data from diverse patient populations.

      HCV-TARGET is a cooperative academic consortium of principal investigators from Clinical and
      Translational Award (CTSA)-funded academic institutions and community-based sites affiliated
      with the academic sites in geographic proximity. The Clinical Coordinating Center (CCC)
      resides at the University of Florida and the Data Coordinating Center (DCC) resides at the
      University of North Carolina at Chapel Hill.

      The HCV-TARGET registry will characterize the population of chronic hepatitis C (HCV)
      patients who are being treated with antiviral therapies at academic and community sites.
      Patient characteristics such as age, race, ethnicity, comorbidity, and disease and treatment
      status will be examined.

      HCV-TARGET will also:

        1. Provide baseline and treatment response data that will be used to pre-identify
           candidates for enrollment in future clinical trials. HCV-TARGET will also develop a
           well-characterized cohort of protease inhibitor treatment failures to be considered for
           future trials.

        2. Establish and maintain data, a specimen bank and other resources for ancillary studies
           of the pathogenesis, diagnosis, natural history and treatment of HCV infection.

      This study will investigate various aspects of treatment response to regimens containing
      direct-acting antiviral agents for the treatment of chronic hepatitis C, including the
      following:

        -  Patients underrepresented in clinical trials of approved antiviral therapies(including
           African-Americans, patients with cirrhosis, and patients that are considered null
           responders to treatment.)

        -  Treatment persistence

        -  Virological breakthrough

        -  Impact of viral load measurement on treatment efficacy

        -  Adverse Event Management and Surveillance.

      The secondary aims for this study will investigate the following:

        -  Sustained virological response (SVR) rates and safety in special populations.

        -  Surveillance of drug-drug interactions.

        -  Treatment and management adherence.

        -  Pretreatment Education in HCV patient population.

        -  Use of specialty pharmacy for hepatitis C therapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained virological response (SVR)</measure>
    <time_frame>24 months</time_frame>
    <description>The primary outcome measure is the occurence (yes or no) of SVR, defined as undetectable HCV RNA in serum at least 3 months after stopping therapy. Point estimates and confidence intervals will be calculated to describe the frequency of SVR in various sub-populations enrolled in HCV-TARGET.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment persistence</measure>
    <time_frame>24 months</time_frame>
    <description>Treatment persistence will be the duration of treatment measured from the first dose of medication until treatment is discontinued. Reasons for premature discontinuation of treatment will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Virological breakthrough</measure>
    <time_frame>24 months</time_frame>
    <description>The occurrence of virological breakthrough defined as an increase of HCV RNA by at least 1-log over nadir or to &gt;100 IU if previously undetectable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Management of adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Specific interventions to manage selected adverse events, such as anemia and skin rash, will be tabulated and described</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4500</enrollment>
  <condition>Hepatitis C</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      All patients will be invited to participate in the HCV-TARGET Biorepository Specimen Bank
      (BSB).

      The following will be collected: Blood (Serum and DNA).

      All samples will be collected on a voluntary basis and participation in this project will not
      affect participation in the main study.

      Samples collected will be stored at the University of Florida for up to 15 years after the
      end of the study (database closure) at which time they will be destroyed. The implementation
      and use of the BSB specimens is governed by the University of Florida Biospecimen Repository
      policy to ensure the appropriate use of the deposited samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female adult patients: Aged 18 and older with chronic HCV treated with triple
        therapy (including protease inhibitors).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients (age 18 or older) being treated with antiviral HCV treatment
             regimens that contain telaprevir or boceprevir.

        Exclusion Criteria:

          -  Inability to provide written informed consent.

          -  Currently participating in another clinical trial of hepatitis C therapeutics. Studies
             comparing HCV RNA assays are not considered exclusionary.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael W. Fried, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David R. Nelson, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic AZ</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Liver Wellness Center</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaniqua Frazier</last_name>
      <phone>501-687-9300</phone>
      <email>chaniquafrazier@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Alonzo Williams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Helen Broussard</last_name>
      <phone>858-652-5419</phone>
      <email>Broussard.MaryHelen@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Paul Pockros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSD Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natali Navarro</last_name>
      <phone>619-471-3922</phone>
      <email>n1navarrocazarez@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Alexander Kuo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSF/San Fran General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Chi Lapid</last_name>
      <email>Yu-Chi.Lapid@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Mandana Khalili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univ of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Falbo</last_name>
      <phone>415-514-3274</phone>
      <email>Steve.Falbo@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Nora Terrault, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer DeSanto, RN</last_name>
      <phone>303-724-1861</phone>
      <email>jennifer.desanto@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>James Burton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University Digestive Diseases</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Sapir</last_name>
      <phone>203-737-6839</phone>
      <email>dana.sapir@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgetown University</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leila Bucary</last_name>
      <email>Leila.Bucary@gunet.georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Coleman Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joy Peter, BSN</last_name>
      <email>joy.peter@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Morelli, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Gulau</last_name>
      <phone>305-243-0311</phone>
      <email>m.gulau@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Schiff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlando Immunology Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff Garrett</last_name>
      <phone>480-342-1328</phone>
      <email>nguyen.vy@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Edwin DeJesus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Medical Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Pearlman, MD</last_name>
      <phone>404-265-1044</phone>
      <email>brianpearlman3@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Brian Pearlman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Solamillo</last_name>
      <phone>312-926-0370</phone>
      <email>jonathan.solamillo@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Josh Levitsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Williams, MSN, RN</last_name>
      <phone>773-702-4477</phone>
      <email>mwillia3@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy Reau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lake Shore Gastroenterology &amp; Liver Disease Inst.</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Mendez, RN</last_name>
      <phone>317-278-4633</phone>
      <email>mwmendez@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Marco Lacerda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Hopkins University</name>
      <address>
        <city>Lutherville</city>
        <state>Maryland</state>
        <zip>21093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Katz, MSN, RN</last_name>
      <phone>443-287-9605</phone>
      <email>SSNEDDO2@JHMI.EDU</email>
    </contact>
    <investigator>
      <last_name>Mark Sulkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachussets General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Gustafson</last_name>
      <phone>617-724-3836</phone>
      <email>JLGustafson@partners.org</email>
    </contact>
    <investigator>
      <last_name>Raymond Chung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harvard University/ Beth Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saima Firdoos</last_name>
      <phone>617-632-1129</phone>
      <email>sfirdoos@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Curry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Balcom, RN</last_name>
      <phone>774-441-7727</phone>
      <email>sharon.balcom@umassmemorial.org</email>
    </contact>
    <investigator>
      <last_name>Gyongyi Szabo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Wu, MPH</last_name>
      <phone>734-647-0236</phone>
      <email>elizwu@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Anna SF Lok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Fleckenstein</last_name>
      <phone>313-916-1962</phone>
      <email>rflecke1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Stuart C Gordon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minnesota Gastro</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teri Carlson</last_name>
      <phone>612-625-0673</phone>
      <email>carls273@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Coleman Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahado Ali, RN</last_name>
      <phone>612-626-1716</phone>
      <email>alixx639@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Mohamed Hassan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karri L Moore</last_name>
      <phone>314-977-9400</phone>
      <email>kmoore35@slu.edu</email>
    </contact>
    <investigator>
      <last_name>Adrian DiBisceglie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Ctr</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Capadano</last_name>
      <phone>402-559-3652</phone>
      <email>mcapadano@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Mailliard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine L. Andrews, RN</last_name>
      <phone>603-653-3668</phone>
      <email>Catherine.L.Andrews@Hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Rolland C Dickson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest CARE Center</name>
      <address>
        <city>Santa Fe</city>
        <state>New Mexico</state>
        <zip>87505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Gallegos</last_name>
      <phone>505-216-1546</phone>
      <email>cgallegos@southwestcare.org</email>
    </contact>
    <investigator>
      <last_name>Trevor N Hawkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hudson River Healthcare</name>
      <address>
        <city>Beacon</city>
        <state>New York</state>
        <zip>12508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Baker</last_name>
      <phone>914-419-3150</phone>
      <email>gbaker@hrhcare.org</email>
    </contact>
    <investigator>
      <last_name>Christine Kerr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Duffie</last_name>
      <phone>646-962-4742</phone>
      <email>wid2006@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Robert S Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennie Chavis</last_name>
      <phone>212-305-3839</phone>
      <email>jc4380@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Verna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mountain View Medical Center</name>
      <address>
        <city>Valatie</city>
        <state>New York</state>
        <zip>12184</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ananth Ramani</last_name>
      <phone>518-943-1943</phone>
      <email>ramani489@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Anathakrishnan Ramani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asheville Gastroenterology Assoc</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kylee S. Diaz</last_name>
      <phone>828-350-3669</phone>
      <email>kylee.diaz@ashevillegastro.com</email>
    </contact>
    <investigator>
      <last_name>Will Harlan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Pritchett, B.A.</last_name>
      <email>tpritch@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Michael W. Fried, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loranda Ross</last_name>
      <phone>919-681-2941</phone>
      <email>loranda.ross@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Anrdrew Muir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Rocky Mount, LLC</name>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <zip>27804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priscilla Miller</last_name>
      <email>Priscilla.miller@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>M Mah'moud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trial Management Associates (TMA)</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Stanbrook, RN, BSN</last_name>
      <phone>513-584-2363</phone>
      <email>LIZ.STAMBROOK@UCHEALTH.COM</email>
    </contact>
    <investigator>
      <last_name>Kenneth Sherman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amina Wirjosemito</last_name>
      <phone>215-615-5471</phone>
      <email>Amina.Wirjosemito@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Rajender Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Dialino</last_name>
      <phone>215-955-8108</phone>
      <email>irene.dialino@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Fenkel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Hepatitis Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Nayor</last_name>
      <phone>512-371-7702</phone>
      <email>george.nayor@acclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Imtiaz Alam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetaClin Research, Inc</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Harbour</last_name>
      <phone>214-820-6243</phone>
      <email>Valerie.Harbour@baylorhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Jacqueline O'Leary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Specialist of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Juarez</last_name>
      <phone>713-634-5110</phone>
      <email>pjuarez@texasliver.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Galati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Metropolitan Liver Diseases and Gastroenterology</name>
      <address>
        <city>Annandale</city>
        <state>Virginia</state>
        <zip>22003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Mary 's Hospital of Richmond (Liver Institute of Virginia)</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Vollum, RN, CRC</last_name>
      <phone>804-977-8921</phone>
      <email>susan_vollum@bshsi.org</email>
    </contact>
    <investigator>
      <last_name>Mitchell L. Shiffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Genther, RN</last_name>
      <phone>804-828-2202</phone>
      <email>kgenther@mcvh-vcu.edu</email>
    </contact>
    <investigator>
      <last_name>Richard K Sterling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Gelinas</last_name>
      <phone>206-341-1992</phone>
      <email>Katharyn.Gelinas@vmmc.org</email>
    </contact>
    <investigator>
      <last_name>James Bredfeldt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Nguyen</last_name>
      <phone>206-744-3402</phone>
      <email>phnmedic@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Landis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liver Clinic, Toronto Western Hospital, UHN</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena Kuczynski</last_name>
      <phone>416-603-5800 x 5086</phone>
      <email>magdalena.Kuczynski@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Jordan Feld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RWTH University Hospital</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Reiss</last_name>
      <phone>0049 241 80 85660</phone>
      <email>mreiss@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Trautwein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>J. W. Goethe University Hospital</name>
      <address>
        <city>Frankfurt</city>
        <zip>DE-60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Barnickel</last_name>
      <phone>0049 69 6301 87769</phone>
      <email>elisabeth.barnickel@kgu.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Zeuzem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanover Medical School</name>
      <address>
        <city>Hanover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carola Mix</last_name>
      <email>mix.carola@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Michael Manns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundacion de investigacion de Diego</name>
      <address>
        <city>San Juan</city>
        <zip>00927</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/25627020</url>
    <description>Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/25218788</url>
    <description>Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/26923436</url>
    <description>Safety and Efficacy of Sofosbuvir-Containing Regimens in Hepatitis C Infected Patients with Impaired Renal Function.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/26519873</url>
    <description>Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/26497081</url>
    <description>Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/27565882</url>
    <description>Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/27418632</url>
    <description>Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/27325691</url>
    <description>Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study.</description>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2011</study_first_submitted>
  <study_first_submitted_qc>November 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2011</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hepatitis</keyword>
  <keyword>Hepatitis C</keyword>
  <keyword>HCV-TARGET</keyword>
  <keyword>HCV</keyword>
  <keyword>Observational Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

